Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-05-000446
Filing Date
2005-02-14
Accepted
2005-02-14 17:25:53
Documents
1
Group Members
PAUL TUDOR JONES, IITHE ALTAR ROCK FUND L.P.THE RAPTOR GLOBAL PORTFOLIO LTD.THE TUDOR BVI GLOBAL PORTFOLIO LTD.TUDOR INVESTMENT CORPORATIONTUDOR PROPRIETARY TRADING, L.L.C.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 - VALEANT PHARMACEUTICALS sc13ga_021005valeant.txt SC 13G/A 29068
  Complete submission text file 0000947871-05-000446.txt   31502
Mailing Address 1275 KING STREET 2ND FLOOR GREENWICH CT 06831-2936
Business Address 1275 KING STREET 2ND FLOOR GREENWICH CT 06831-2936
TUDOR INVESTMENT CORP ET AL (Filed by) CIK: 0000923093 (see all company filings)

EIN.: 000000000
Type: SC 13G/A

Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7145450100
VALEANT PHARMACEUTICALS INTERNATIONAL (Subject) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44365 | Film No.: 05612808
SIC: 2834 Pharmaceutical Preparations